Hormone therapy use after treatment for nonserous epithelial ovarian cancer was not tied to reduced overall survival, and may have extended disease-free survival in women younger than 55 years.
Medscape Medical News …read more
Hormone therapy use after treatment for nonserous epithelial ovarian cancer was not tied to reduced overall survival, and may have extended disease-free survival in women younger than 55 years.
Medscape Medical News …read more